• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

TLT-1s 是髓样细胞触发受体样转录物-1(TLT-1)的替代转录本,在破骨细胞发生过程中抑制髓样细胞触发受体-2(TREM-2)介导的信号通路。

TLT-1s, alternative transcripts of triggering receptor expressed on myeloid cell-like transcript-1 (TLT-1), Inhibits the triggering receptor expressed on myeloid cell-2 (TREM-2)-mediated signaling pathway during osteoclastogenesis.

机构信息

Department of Cell and Developmental Biology, BK21 and DRI, Seoul National University, Seoul, Korea.

出版信息

J Biol Chem. 2012 Aug 24;287(35):29620-6. doi: 10.1074/jbc.M112.351239. Epub 2012 Jul 3.

DOI:10.1074/jbc.M112.351239
PMID:22761415
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3436187/
Abstract

Triggering receptor expressed on myeloid cells (TREM)-like transcript-1 (TLT-1) is an immunoreceptor tyrosine-based inhibitory motif (ITIM)-baring TREM family protein. In this study, we identified an alternative transcript form of TLT-1, namely TLT-1s, which has very short extracellular immunoglobulin domain consisting of only 202 amino acids. TLT-1s was mainly expressed in macrophages and osteoclast precursor cells. Upon receptor activator of nuclear factor-κB ligand stimulation, TLT-1s mRNA and protein levels were gradually decreased in BMMs. We also showed the TLT-1s is localized to the cytoplasmic membrane in osteoclast precursor cells. TLT-1s silencing strongly enhanced the formation and resorption activity of osteoclast. In addition, forced expression of TLT-1s showed reduced formation of osteoclast. Because ITIM-baring proteins inhibit immunoreceptor tyrosine-based activation motif (ITAM)-mediated receptor signaling, we tested whether TLT-1s physically interacted with TREM-2, the ITAM-associated co-stimulatory receptor essential for osteoclast differentiation. We showed that TLT-1s is associated with TREM-2 in osteoclast precursor cells. TLT-1s is also associated with tyrosine Src homology 2 domain-containing phosphatase-1 and SH2 domain-containing inositol phosphatase-1 and recruited them to the TREM2-ITAM signaling complex. In addition, knockdown of TLT-1s markedly elevated the intracellular calcium concentration and oscillation in osteoclast precursor cells. In addition, calcium-mediated induction of nuclear factor of activated T cells was also increased by TLT-1s silencing. Furthermore, TREM-2-mediated Akt activation and proliferation of osteoclast precursor cells were also enhanced in TLT-1s silenced cells. In this paper, we found the noble ITIM-baring inhibitory membrane protein; TLT-1s, which regulates ITAM-mediated signaling on osteoclastogenesis.

摘要

触发受体表达在髓样细胞(TREM)样转录本-1(TLT-1)是一种免疫受体酪氨酸的基于抑制基序(ITIM)的TREM 家族蛋白。在这项研究中,我们鉴定了 TLT-1 的一种替代转录本形式,即 TLT-1s,其具有非常短的细胞外免疫球蛋白结构域,仅由 202 个氨基酸组成。TLT-1s 主要在巨噬细胞和破骨细胞前体细胞中表达。在核因子-κB 受体激活剂配体刺激下,TLT-1s mRNA 和蛋白水平在 BMMs 中逐渐降低。我们还表明 TLT-1s 在破骨细胞前体细胞中定位于质膜。TLT-1s 的沉默强烈增强了破骨细胞的形成和吸收活性。此外,TLT-1s 的强制表达显示出破骨细胞形成减少。因为 ITIM 携带蛋白抑制免疫受体酪氨酸的基于激活基序(ITAM)的受体信号,我们测试了 TLT-1s 是否与 TREM-2 物理相互作用,TREM-2 是破骨细胞分化所必需的 ITAM 相关共刺激受体。我们表明 TLT-1s 在破骨细胞前体细胞中与 TREM-2 相关。TLT-1s 也与酪氨酸 Src 同源 2 结构域含有磷酸酶-1 和 SH2 结构域含有肌醇磷酸酶-1 相关,并将它们募集到 TREM2-ITAM 信号复合物中。此外,TLT-1s 的敲低显著增加了破骨细胞前体细胞中的细胞内钙浓度和振荡。此外,TLT-1s 的敲低也增加了钙介导的活化 T 细胞核因子的诱导。此外,TREM-2 介导的 Akt 激活和破骨细胞前体细胞的增殖也在 TLT-1s 敲低的细胞中增强。在本文中,我们发现了一种高尚的 ITIM 携带抑制性膜蛋白;TLT-1s,它调节破骨细胞发生中的 ITAM 介导的信号。

相似文献

1
TLT-1s, alternative transcripts of triggering receptor expressed on myeloid cell-like transcript-1 (TLT-1), Inhibits the triggering receptor expressed on myeloid cell-2 (TREM-2)-mediated signaling pathway during osteoclastogenesis.TLT-1s 是髓样细胞触发受体样转录物-1(TLT-1)的替代转录本,在破骨细胞发生过程中抑制髓样细胞触发受体-2(TREM-2)介导的信号通路。
J Biol Chem. 2012 Aug 24;287(35):29620-6. doi: 10.1074/jbc.M112.351239. Epub 2012 Jul 3.
2
Cutting edge: TREM-like transcript-1, a platelet immunoreceptor tyrosine-based inhibition motif encoding costimulatory immunoreceptor that enhances, rather than inhibits, calcium signaling via SHP-2.前沿:类触发受体表达分子-1,一种编码共刺激免疫受体的血小板免疫受体酪氨酸抑制基序,其通过SHP-2增强而非抑制钙信号传导。
J Immunol. 2004 May 15;172(10):5838-42. doi: 10.4049/jimmunol.172.10.5838.
3
Contribution of nuclear factor of activated T cells c1 to the transcriptional control of immunoreceptor osteoclast-associated receptor but not triggering receptor expressed by myeloid cells-2 during osteoclastogenesis.活化T细胞核因子c1在破骨细胞生成过程中对免疫受体破骨细胞相关受体而非髓样细胞表达的触发受体-2转录调控的作用。
J Biol Chem. 2005 Sep 23;280(38):32905-13. doi: 10.1074/jbc.M505820200. Epub 2005 Jul 26.
4
Interleukin-27 inhibits human osteoclastogenesis by abrogating RANKL-mediated induction of nuclear factor of activated T cells c1 and suppressing proximal RANK signaling.白细胞介素-27通过消除RANKL介导的活化T细胞核因子c1的诱导并抑制近端RANK信号传导来抑制人破骨细胞生成。
Arthritis Rheum. 2010 Feb;62(2):402-13. doi: 10.1002/art.27200.
5
Initial characterization of TREM-like transcript (TLT)-1: a putative inhibitory receptor within the TREM cluster.类触发受体(TREM)样转录本(TLT)-1的初步特征:TREM簇中的一种假定抑制性受体。
Blood. 2002 Nov 15;100(10):3822-4. doi: 10.1182/blood-2002-02-0523. Epub 2002 Jul 12.
6
Regulation of ITAM adaptor molecules and their receptors by inhibition of calcineurin-NFAT signalling during late stage osteoclast differentiation.在晚期破骨细胞分化过程中,通过抑制钙调神经磷酸酶-NFAT 信号传导来调节 ITAM 衔接分子及其受体。
Biochem Biophys Res Commun. 2012 Oct 19;427(2):404-9. doi: 10.1016/j.bbrc.2012.09.077. Epub 2012 Sep 20.
7
A Comprehensive Review of Immunoreceptor Regulation of Osteoclasts.破骨细胞免疫受体调控的综合综述
Clin Rev Allergy Immunol. 2016 Aug;51(1):48-58. doi: 10.1007/s12016-015-8521-8.
8
A New Triggering Receptor Expressed on Myeloid Cells (TREM) Family Member, TLT-6, is Involved in Activation and Proliferation of Macrophages.髓系细胞表达的新型触发受体(TREM)家族成员TLT-6参与巨噬细胞的激活和增殖。
Immune Netw. 2015 Oct;15(5):232-40. doi: 10.4110/in.2015.15.5.232. Epub 2015 Oct 26.
9
Receptor activator of NF-kappa B ligand stimulates recruitment of SHP-1 to the complex containing TNFR-associated factor 6 that regulates osteoclastogenesis.核因子κB受体激活剂配体刺激含肿瘤坏死因子受体相关因子6的复合物募集含Src同源2结构域蛋白酪氨酸磷酸酶-1,该复合物调节破骨细胞生成。
J Immunol. 2003 Oct 1;171(7):3620-6. doi: 10.4049/jimmunol.171.7.3620.
10
Mechanistic insight into osteoclast differentiation in osteoimmunology.骨免疫学中破骨细胞分化的机制性见解。
J Mol Med (Berl). 2005 Mar;83(3):170-9. doi: 10.1007/s00109-004-0612-6. Epub 2005 Jan 26.

引用本文的文献

1
Small molecules as ligands in the tuning of immune regulatory receptors.小分子作为调节免疫调节受体的配体。
Front Immunol. 2025 Aug 29;16:1648691. doi: 10.3389/fimmu.2025.1648691. eCollection 2025.
2
Transcriptomic Characterization Reveals Mitochondrial Involvement in Nrf2/Keap1-Mediated Osteoclastogenesis.转录组学特征揭示线粒体参与Nrf2/Keap1介导的破骨细胞生成过程。
Antioxidants (Basel). 2024 Dec 20;13(12):1575. doi: 10.3390/antiox13121575.
3
The emerging role of triggering receptor expressed on myeloid cell-2 in malignant tumor.髓样细胞2上表达的触发受体在恶性肿瘤中的新作用。
Cent Eur J Immunol. 2022;47(4):373-381. doi: 10.5114/ceji.2022.124387. Epub 2023 Jan 31.
4
The enigmatic nature of the triggering receptor expressed in myeloid cells -1 (TLT- 1).髓系细胞表达的触发受体-1(TLT-1)的神秘性质。
Platelets. 2021 Aug 18;32(6):753-760. doi: 10.1080/09537104.2021.1881948. Epub 2021 Feb 9.
5
Platelet biology of the rapidly failing lung.迅速衰竭肺的血小板生物学。
Br J Haematol. 2020 Mar;188(5):641-651. doi: 10.1111/bjh.16315. Epub 2019 Nov 7.
6
Platelet-derived TLT-1 is a prognostic indicator in ALI/ARDS and prevents tissue damage in the lungs in a mouse model.血小板衍生的 TLT-1 是 ALI/ARDS 的预后指标,并可在小鼠模型中防止肺部组织损伤。
Blood. 2018 Dec 6;132(23):2495-2505. doi: 10.1182/blood-2018-03-841593. Epub 2018 Oct 3.
7
The Characterization of Monoclonal Antibodies to Mouse TLT-1 Suggests That TLT-1 Plays a Role in Wound Healing.针对小鼠TLT-1的单克隆抗体的特性表明,TLT-1在伤口愈合中发挥作用。
Monoclon Antib Immunodiagn Immunother. 2018 Apr;37(2):78-86. doi: 10.1089/mab.2017.0063.
8
TREM2 in Neurodegenerative Diseases.TREM2 在神经退行性疾病中的作用。
Mol Neurodegener. 2017 Aug 2;12(1):56. doi: 10.1186/s13024-017-0197-5.
9
Emerging Roles for Platelets in Inflammation and Disease.血小板在炎症和疾病中的新作用
J Infect Dis Ther. 2014 Aug;2(4). doi: 10.4172/2332-0877.1000149. Epub 2014 Jun 24.
10
TREM2-Ligand Interactions in Health and Disease.健康与疾病中的TREM2配体相互作用
J Mol Biol. 2017 Jun 2;429(11):1607-1629. doi: 10.1016/j.jmb.2017.04.004. Epub 2017 Apr 19.

本文引用的文献

1
Development of severe skeletal defects in induced SHP-2-deficient adult mice: a model of skeletal malformation in humans with SHP-2 mutations.诱导 SHP-2 缺陷的成年小鼠中严重骨骼缺陷的发展:SHP-2 突变人类骨骼畸形的模型。
Dis Model Mech. 2011 Mar;4(2):228-39. doi: 10.1242/dmm.006130. Epub 2010 Nov 10.
2
Cytoskeletal dysfunction dominates in DAP12-deficient osteoclasts.细胞骨架功能障碍在 DAP12 缺陷破骨细胞中占主导地位。
J Cell Sci. 2010 Sep 1;123(Pt 17):2955-63. doi: 10.1242/jcs.069872.
3
Ly49Q, an ITIM-bearing NK receptor, positively regulates osteoclast differentiation.LY49Q,一种带有 ITIM 的 NK 受体,正向调节破骨细胞分化。
Biochem Biophys Res Commun. 2010 Mar 12;393(3):432-8. doi: 10.1016/j.bbrc.2010.02.013. Epub 2010 Feb 12.
4
TREM-like transcript-1 protects against inflammation-associated hemorrhage by facilitating platelet aggregation in mice and humans.类触发受体表达分子-1通过促进小鼠和人类的血小板聚集来预防炎症相关出血。
J Clin Invest. 2009 Jun;119(6):1489-501. doi: 10.1172/JCI36175. Epub 2009 May 11.
5
Inhibitory immunoglobulin-like receptors LILRB and PIR-B negatively regulate osteoclast development.抑制性免疫球蛋白样受体LILRB和PIR-B对破骨细胞的发育起负向调节作用。
J Immunol. 2008 Oct 1;181(7):4742-51. doi: 10.4049/jimmunol.181.7.4742.
6
The JNK-dependent CaMK pathway restrains the reversion of committed cells during osteoclast differentiation.JNK 依赖的 CaMK 通路在破骨细胞分化过程中抑制定向细胞的逆转。
J Cell Sci. 2008 Aug 1;121(Pt 15):2555-64. doi: 10.1242/jcs.028217.
7
Suppression of osteoclastogenesis by N,N-dimethyl-D-erythro-sphingosine: a sphingosine kinase inhibition-independent action.N,N-二甲基-D-赤藓糖神经鞘氨醇对破骨细胞生成的抑制作用:一种不依赖于鞘氨醇激酶抑制的作用。
Mol Pharmacol. 2007 Aug;72(2):418-28. doi: 10.1124/mol.107.034173. Epub 2007 May 15.
8
The TREM receptor family and signal integration.触发受体表达分子(TREM)受体家族与信号整合
Nat Immunol. 2006 Dec;7(12):1266-73. doi: 10.1038/ni1411.
9
PLCgamma2 regulates osteoclastogenesis via its interaction with ITAM proteins and GAB2.磷脂酶Cγ2通过与免疫受体酪氨酸激活基序(ITAM)蛋白和Grb2相关结合蛋白2(GAB2)相互作用来调节破骨细胞生成。
J Clin Invest. 2006 Nov;116(11):2869-79. doi: 10.1172/JCI28775. Epub 2006 Oct 19.
10
You say ITAM and I say ITIM, let's call the whole thing off: the ambiguity of immunoreceptor signalling.你说免疫受体酪氨酸激活基序(ITAM),我说免疫受体酪氨酸抑制基序(ITIM),那我们别再纠结了:免疫受体信号传导的模糊性。
Eur J Immunol. 2006 Jul;36(7):1646-53. doi: 10.1002/eji.200636195.